Current evidence and future role of robot-assisted CT-guided interventions

Robot-assisted CT interventions improve targeting precision, reduce needle adjustments and operator radiation exposure in complex procedures (liver, lung, kidney, MSK). Evidence remains at IDEAL stages 1-2b; not yet standard of care. Emerging randomised trials may change that.

• Clinical evidence is concentrated in liver, lung, kidney, and musculoskeletal biopsies/ablations, particularly for long, oblique, and out-of-plane trajectories.
• Systems demonstrate improved targeting precision and fewer needle adjustments, while operator radiation exposure is frequently reduced; procedure time and patient dose effects vary.
• Most studies are at IDEAL stages 1-2b; wider adoption awaits robust comparative trials, economic evaluation, and structured implementation.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.